Frontiers in Oncology | Breast Cancer

Systematic Review

Published on 27 Jun 2024

Mechanisms of traditional Chinese medicine overcoming of radiotherapy resistance in breast cancer

in Breast Cancer

Xiaohui Zhao
Ting Luo
Yuting Qiu
Zhiwei Yang
Danni Wang
Zairui Wang
Jiale Zeng
Zhuofei Bi

Frontiers in Oncology

doi 10.3389/fonc.2024.1388750

1,810 views

Original Research

Published on 26 Jun 2024

Low progesterone receptor levels in high-grade DCIS correlate with HER2 upregulation and the presence of invasive components

in Breast Cancer

Hossein Schandiz
Lorant Farkas
Daehoon Park
Yan Liu
Solveig N. Andersen
Jürgen Geisler
Torill Sauer

Frontiers in Oncology

doi 10.3389/fonc.2024.1347166

1,555 views
1 citation

Original Research

Published on 24 Jun 2024

Long-term oncologic outcomes following breast cancer surgery in adolescents and young adults: a single-center retrospective analysis

in Breast Cancer

Xin Liu
Zengyan Ma
Hongwu Chu
Weihong Nie
Guoxin Sun
Kaihua Zhao
Xiao Zou

Frontiers in Oncology

doi 10.3389/fonc.2024.1364608

1,101 views

Systematic Review

Published on 24 Jun 2024

Germline rare variants in HER2-positive breast cancer predisposition: a systematic review and meta-analysis

in Breast Cancer

Angelica Cerveira de Baumont
Nathan Araujo Cadore
Luana Giongo Pedrotti
Giovana Dallaio Curzel
Jaqueline Bohrer Schuch
Marina Bessel
Cláudia Bordignon
Mahira Lopes Rosa
Gabriel de Souza Macedo
Daniela Dornelles Rosa

Frontiers in Oncology

doi 10.3389/fonc.2024.1395970

2,288 views
2 citations

Case Report

Published on 20 Jun 2024

Recurrent and transformation of borderline to malignant phyllodes tumour with osteoid differentiation: a case report and literature review

in Breast Cancer

Navin Raj Balachandran
Norlia Abdullah
Muhammad Ishamuddin Ismail
Yin Ping Wong
Mohd Imree Azmi

Frontiers in Oncology

doi 10.3389/fonc.2024.1377074

1,369 views
1 citation

Original Research

Published on 20 Jun 2024

The global burden of breast cancer in women from 1990 to 2030: assessment and projection based on the global burden of disease study 2019

in Breast Cancer

Song Zhang
Zhihui Jin
Lingling Bao
Peng Shu

Frontiers in Oncology

doi 10.3389/fonc.2024.1364397

5,369 views
7 citations

Original Research

Published on 18 Jun 2024

Is the percentage of hormone receptor positivity in HR+ HER2-metastatic breast cancer patients receiving CDK 4/6 inhibitor with endocrine therapy predictive and prognostic?

in Breast Cancer

Merve Keskinkilic
Huseyin Salih Semiz
Tugba Yavuzsen
Ilhan Oztop

Frontiers in Oncology

doi 10.3389/fonc.2024.1378563

1,756 views

Case Report

Published on 17 Jun 2024

Partial response to trastuzumab deruxtecan (DS8201) following progression in HER2-amplified breast cancer with pulmonary metastases managed with disitamab vedotin (RC48): a comprehensive case report and literature review

in Breast Cancer

Yanfang Lan
Jiahui Zhao
Fangrui Zhao
Juanjuan Li
Xiangpan Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1338661

2,061 views

Original Research

Published on 17 Jun 2024

The somatic mutation profile of estrogen receptor-positive HER2-negative metastatic breast cancer in Brazilian patients

in Breast Cancer

Tomás Reinert
Fernanda Orpinelli do Rego
Matheus Costa e Silva
Amanda Muniz Rodrigues
Fernanda Christtanini Koyama
Aline Coelho Gonçalves
Maiane Maria Pauletto
Leandro Jonata de Carvalho Oliveira
Cristiano Augusto Andrade de Resende
Luciana Castro Garcia Landeiro

Frontiers in Oncology

doi 10.3389/fonc.2024.1372947

2,639 views
2 citations

Original Research

Published on 14 Jun 2024

Relationship between age at menarche and breast cancer in individuals, as well as in first-degree kin and estrogen receptor status: a Mendelian randomization study

in Breast Cancer

Zhijun Zhao
Jinming Zhang
Xiaofeng Tian

Frontiers in Oncology

doi 10.3389/fonc.2024.1408132

1,616 views

Original Research

Published on 14 Jun 2024

Development and validation of AI models using LR and LightGBM for predicting distant metastasis in breast cancer: a dual-center study

in Breast Cancer

Wen-hai Zhang
Yang Tan
Zhen Huang
Qi-xing Tan
Yue-mei Zhang
Bin-jie Chen
Chang-yuan Wei

Frontiers in Oncology

doi 10.3389/fonc.2024.1409273

1,309 views

Case Report

Published on 11 Jun 2024

Hemophagocytic lymphohistiocytosis/cytokine release syndrome secondary to neoadjuvant pembrolizumab for triple-negative breast cancer: a case study

in Breast Cancer

Laura Patton
Bethany Monteith
Paul Heffernan
Thomas Herzinger
Brooke E. Wilson

Frontiers in Oncology

doi 10.3389/fonc.2024.1394543

1,931 views
2 citations

Original Research

Published on 10 Jun 2024

Triple-negative breast cancer survival prediction: population-based research using the SEER database and an external validation cohort

in Breast Cancer

Yu Qiu
Yan Chen
Haoyang Shen
Shuixin Yan
Jiadi Li
Weizhu Wu

Frontiers in Oncology

doi 10.3389/fonc.2024.1388869

2,221 views

Original Research

Published on 07 Jun 2024

Tailoring advanced breast cancer treatment after cyclin-dependent kinase 4/6 inhibitors progression - real-world data analysis

in Breast Cancer

Marcin Kubeczko
Anna Polakiewicz-Gilowska
Katarzyna Świderska
Aleksandra Leśniak
Marta Mianowska-Malec
Barbarba Łanoszka
Konstanty Chomik
Barbara Grandys
Natalya Lisovska
Barbara Bobek-Billewicz

Frontiers in Oncology

doi 10.3389/fonc.2024.1408664

2,061 views

Systematic Review

Published on 06 Jun 2024

Effect of frozen gloves on chemotherapy-induced neurotoxicity in breast cancer patients: a systematic review and meta-analysis

in Breast Cancer

Hongting Wu
Ying Jin
Jiaqing Song
Xiufei Gao

Frontiers in Oncology

doi 10.3389/fonc.2024.1366782

3,335 views
1 citation

Correction

Published on 06 Jun 2024

Corrigendum: Ultrasound-based radiomics analysis for differentiating benign and malignant breast lesions: from static images to CEUS video analysis

in Breast Cancer

Jun-Yan Zhu
Han-Lu He
Zi-Mei Lin
Jian-Qiang Zhao
Xiao-Chun Jiang
Zhe-Hao Liang
Xiao-Ping Huang
Hai-Wei Bao
Pin-Tong Huang
Fen Chen

Frontiers in Oncology

doi 10.3389/fonc.2024.1436117

844 views